These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effects of nitric oxide on antral motility and gastric emptying in humans. Konturek JW; Thor P; Domschke W Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):97-102. PubMed ID: 7712314 [TBL] [Abstract][Full Text] [Related]
24. Effect of ageing on the gastro-intestinal transit of a lactulose-supplemented mixed solid-liquid meal in humans. Wegener M; Börsch G; Schaffstein J; Lüth I; Rickels R; Ricken D Digestion; 1988; 39(1):40-6. PubMed ID: 3396772 [TBL] [Abstract][Full Text] [Related]
26. Intragastric Lysine Lowers the Circulating Glucose and Insulin Responses to a Mixed-Nutrient Drink without Slowing Gastric Emptying in Healthy Adults. Ullrich SS; Fitzgerald PC; Nkamba I; Steinert RE; Horowitz M; Feinle-Bisset C J Nutr; 2017 Jul; 147(7):1275-1281. PubMed ID: 28592515 [No Abstract] [Full Text] [Related]
27. Effect of euglycaemic hyperinsulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects. Kong MF; King P; Macdonald IA; Blackshaw PE; Perkins AC; Armstrong E; Buchanan KD; Tattersall RB Diabetologia; 1998 Apr; 41(4):474-81. PubMed ID: 9562353 [TBL] [Abstract][Full Text] [Related]
28. Gastric emptying and small bowel transit times in volunteers after intravenous morphine and nalbuphine. Yukioka H; Rosen M; Evans KT; Leach KG; Hayward MW; Saggu GS Anaesthesia; 1987 Jul; 42(7):704-10. PubMed ID: 3631471 [TBL] [Abstract][Full Text] [Related]
29. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients. Lamberts SW; Oosterom R; Neufeld M; del Pozo E J Clin Endocrinol Metab; 1985 Jun; 60(6):1161-5. PubMed ID: 2860119 [TBL] [Abstract][Full Text] [Related]
30. The effect of trimebutine maleate on gastric emptying in patients with non-ulcer dyspepsia. Aktas A; Caner B; Ozturk F; Bayhan H; Narin Y; Mentes T Ann Nucl Med; 1999 Aug; 13(4):231-4. PubMed ID: 10510878 [TBL] [Abstract][Full Text] [Related]
31. Preliminary studies on the gastrointestinal responses to fatty meals in obese people. French SJ; Murray B; Rumsey RD; Sepple CP; Read NW Int J Obes Relat Metab Disord; 1993 May; 17(5):295-300. PubMed ID: 8389339 [TBL] [Abstract][Full Text] [Related]
32. The nitric oxide synthase inhibitor, Ng-nitro-L-arginine-methyl-ester, attenuates the delay in gastric emptying induced by hyperglycaemia in healthy humans. Kuo P; Gentilcore D; Nair N; Stevens JE; Wishart JM; Lange K; Gilja OH; Hausken T; Horowitz M; Jones KL; Rayner CK Neurogastroenterol Motil; 2009 Nov; 21(11):1175-e103. PubMed ID: 19460102 [TBL] [Abstract][Full Text] [Related]
33. Effect of subcutaneous injection of a long-acting analogue of somatostatin (SMS 201-995) on plasma thyroid-stimulating hormone in normal human subjects. Itoh S; Tanaka K; Kumagae M; Takeda F; Morio K; Kogure M; Hasegawa M; Horiuchi T; Watabe T; Miyabe S Life Sci; 1988; 42(26):2691-9. PubMed ID: 2898717 [TBL] [Abstract][Full Text] [Related]
34. Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Johansson C; Wisén O; Efendić S; Uvnäs-Wallensten K Digestion; 1981; 22(3):126-37. PubMed ID: 6116637 [No Abstract] [Full Text] [Related]
35. Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans. Lamrani A; Vidon N; Sogni P; Nepveux P; Catus F; Blumberg J; Chaussade S Br J Clin Pharmacol; 1997 Jan; 43(1):65-70. PubMed ID: 9056054 [TBL] [Abstract][Full Text] [Related]
36. Treatment of postprandial hypotension with a somatostatin analogue (SMS 201-995). Hoeldtke RD; Boden G; O'Dorisio TM Am J Med; 1986 Dec; 81(6B):83-7. PubMed ID: 2879451 [TBL] [Abstract][Full Text] [Related]
37. Effect of metoclopramide, bethanechol, and loperamide on gastric residence time, gastric emptying, and mouth-to-cecum transit time. Kirby MG; Dukes GE; Heizer WD; Bryson JC; Powell JR Pharmacotherapy; 1989; 9(4):226-31. PubMed ID: 2771808 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Bauer FE; Zintel A; Kenny MJ; Calder D; Ghatei MA; Bloom SR Gastroenterology; 1989 Aug; 97(2):260-4. PubMed ID: 2472997 [TBL] [Abstract][Full Text] [Related]
39. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans. Liddle RA; Rushakoff RJ; Morita ET; Beccaria L; Carter JD; Goldfine ID J Clin Invest; 1988 Jun; 81(6):1675-81. PubMed ID: 3290250 [TBL] [Abstract][Full Text] [Related]
40. The effect of gastric secretion on orocoecal transit time measured with the hydrogen (H2) breath test. Armbrecht U; Dotevall G; Stockbrügger RW Z Gastroenterol; 1987 Mar; 25(3):145-50. PubMed ID: 3590893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]